View Author
patient dialysis study protein dialysate igf-i kidney synthesis aureus leucine infection glucose solution effect igf-i bioactivity treatment intake protein synthesis method state level table transplantation peritoniti result g dialysis factor g dialysate albumin nephrol carriage plasma carrier capd patients sclerosis period encapsulating tamoxifen bioactivity dialysis patients kidney transplantation paclitaxel infusion eps patients carboplatin protein intake staphylococcus aureus transplant strain erasmus university rotterdam university cancer signi culture rotterdam signi ficantly diagnosis group analysis pd patients difference month malnutrition insulin disease whole-body protein turnover vancomycin blood serum staphylococcus erasmu intraperitoneal protein breakdown fasting breakdown incidence nitrogen cpd-related balance whole-body
10 Most Recent Publications
|
Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study
(Article)
Korte, M.R. Sampimon, D.E. Roozenbeek, B. Fieren, M.W.J.A. Looman, C.W.N. Zietse, R. Weimar, W. Betjes, M.G.H. |
2011-05-01
|
|
Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: Results of the Dutch Multicentre EPS Study
(Article)
Korte, M.R. Fieren, M.W.J.A. Sampimon, D.E. Roozenbeek, B. Weimar, W. Betjes, M.G.H. |
2011-02-01
|
|
Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients
(Article)
Brugts, M.P. Tjiong, H.L. Rietveld, T. Wattimena, J.L. Berg, J.W.O. van den Fieren, M.W.J.A. Janssen, J.A.M.J.L. |
2010-03-01
|
|
Continuous ambulatory peritoneal dialysis: Pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
(Article)
Heijns, J.B. Burg, M.E.L. van der Gelder, T. van Fieren, M.W.J.A. Bruijn, P. de Gaast, A. van der Loos, W.J. |
2008-10-01
|
|
Dialysate as food as an option for automated peritoneal dialysis
(Article)
Tjiong, H.L. Swart, R. Berg, J.W.O. van den Fieren, M.W.J.A. |
2008-10-01
|
|
Whole-body protein turnover in peritoneal dialysis patients: A comparison of the [15N]glycine end product and the [13C]leucine precursor methods
(Article)
Tjiong, H.L. Swart, R. Rietveld, T. Wattimena, J.L. Hop, W.C.J. Fieren, M.W.J.A. Berg, J.W.V.D. |
2008-08-01
|
|
Peritoneal protein losses and cytokine generation in automated peritoneal dialysis with combined amino acids and glucose solutions
(Article)
Tjiong, H.L. Zijlstra, F.J. Rietveld, T. Wattimena, J.L. Huijmans, J. Swart, G.R. Fieren, M.W.J.A. |
2007-12-01
|
|
Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids
(Article)
Tjiong, H.L. Fieren, M.W.J.A. Rietveld, T. Wattimena, J.L. Schierbeek, H. Huijmans, J. Hop, W.C.J. Swart, G.R. Berg, J.W.O. van den |
2007-08-01
|
|
Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation [10]
(Article)
Korte, M.R. Yo, M. Betjes, M.G.H. Fieren, M.W.J.A. Saase, J.C.L.M. van Boer, W.H. Weimar, W. Zietse, R. |
2007-08-01
|
|
Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding
(Article)
Tjiong, H.L. Rietveld, T. Wattimena, J.L. Berg, J.W.O. van den Kahriman, D. Steen, J. van der Hop, W.C.J. Swart, R. Fieren, M.W.J.A. |
2007-01-01
|
